NDC 53157-455

Leukotrap - CP2D

Anticoagulant Citrate Phosphate Double Dextrose

Leukotrap - CP2D is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Corporation. The primary component is Dextrose, Unspecified Form.

• Product ID: 53157-455_e154f8b7-89a1-dfbb-e053-2995a90a300a
• NDC: 53157-455
• Product Type: Human Prescription Drug
• Proprietary Name: Leukotrap - CP2D
• Generic Name: Anticoagulant Citrate Phosphate Double Dextrose
• Dosage Form: Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2019-10-09
• Marketing Category: NDA /
• Application Number: BN820915
• Labeler Name: Haemonetics Corporation
• Substance Name: DEXTROSE, UNSPECIFIED FORM
• Active Ingredient Strength: 5 g/100mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 53157-455-02

250 mL in 1 BAG (53157-455-02)

• Marketing Start Date: 2019-10-09
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Leukotrap - CP2D" or generic name "Anticoagulant Citrate Phosphate Double Dextrose"

NDC	Brand Name	Generic Name
53157-455	Leukotrap - CP2D	ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE
53157-123	Leukotrap - CP2D Solution	Anticoagulant Citrate Phosphate Double Dextrose